Chang P, Rodríguez PR

Language: Spanish
References: 25
Page: 199-202
PDF size: 235.21 Kb.

ABSTRACT

Case report of exogenous ochronosis in a 50 year-old female with a history of kidney failure and blackish facial dyschromia from long-term use of hydroquinone.

REFERENCES

1. Vélez H, Borrero J. Restrepo J, Rojas W. “Diccionario dermatológico. Dermatología Fundamentos de Medicina”. 7ª ed., Corporación para investigaciones Biológicas, Medellin, Colombia, 2009, p. 93.

2. Levyn C, Maibach H. “Exogenous ochronosis: an update on clinical features, causative agents and treatment options”. Am J Clin Dermatol 2001; 2(4): 213-217.

3. Fernández K. “Ocronosis exógena localizada”. Dermatología Venezolana 2005; 43(2): 34.

4. Snider R, Thiers B. “Exogenous Ochronosis”. J Am Acad Dermatol 1993; 28(1): 662-664.

5. Zawar VP, Mhaskar ST. “Exogenous ochronosis following hydroquinone for melasma”. J Cosmet Dermatol 2004; 3: 234-236.

6. Kundu R. “Consideraciones especiales para el tratamiento tópico de la piel de determinados grupos étnicos”. En: Wolf K, Goldsmith L, et al. Dermatología en Medicina General, 7ª ed, Buenos Aires, Editorial Médica Panamericana, 2009, pp. 2142-2143.

7. Jordan H, Van Niekerk D. “Transepidermal elimination in exogenous ochronosis. A report of two cases”. Am J Dermatopathol 1991; 13: 418-424.

8. Picardo M, Carrera M. “New experimental treatments for melasma and other hyperpigmentations”. Dermatol Clin 2007; 25: 353-362.

9. Olumide Y, Akinkugbe A, Altraide D. “Complications of chronic use of skin lightening cosmetics”. Int J Derm 2008; 47: 344-353.

10. Dogliotte M, Liebowitz M. Granulomatous ochronosis –a cosmeticinduced skin disorder in blacks. S Afr Med J 1979; 56:757-60.

11. Findley G, Morrison J, Simon I. “Exogenous ochronosis and pigmented colloidmilium from hydroquinone bleaching creams”. Br J Dermatol 1975; 93: 613-622.

12. Del Giudice P, Yves P. “The widespread use of skin lightening creams in Senegal: a persistent public healt problem in West Africa”. Int J Dermatol 2002; 41(2): 69-72.

13. Rose P. “Pigmentary disorders”. Med Clin N Am 2009; 93: 1225-1239.

14. Rivas J, Schettini A, Cavalcante M. “Exogenous ochronosis hydroquinone induced: a report of four cases”. An Bras Dermatol 2010; 85(5): 699-703.

15. Vargas F, Valdez P, Arenas R. “La ocronosis exógena: ¿Qué tanto la diagnosticamos o la diferenciamos del melasma?” Dermatol CMQ 2012; 10(2): 143-147.

16. Hardwick N, Van Gelder L, Van Der Merwe C. “Exogenous ochronosis: an epidemiological study”. Br J Dermatol 1989; 120: 229-238.

17. Hall J. “Alergia Dermatológica”. En: Hall J. Sauer Manual de enfermedades de la piel, 9ª ed, Barcelona, Lippincott Williams & Wilkins, 2008.

18. Levitt J. “The safety of hydroquinone: A dermatologist’s response to the 2006 Federal Register”. J Am Acad Dermatol 2007; 57: 854-872.

19. Tidman M, Horton J, MacDonald D. “Hydroquinone-induced ochronosis- light and electronmicroscopic features”. Clin Exp Dermatol 198; 11: 224-228.

20. Hull P, Procter P. “The melanocyte: an essential link in hydroquinone- induced ochronosis”. J Am Acad Dermatol 1990; 22: 529-531.

21. Gil I, Segura S, Martínez E, Lloreta J, Puig S, Vélez M, et al. “Dermoscopic and Reflectance Confocal Microscopic Features of Exogenous Ochronosis”. Arch Dermatol Barcelona 2010; 146(9): 1021-1025

22. Falabella R. “Pigmentary disorders in Latin America”. Dermatol Clin 2007; 25: 419-430.

23. Tan S. “Exogenous ochronosis in etnic Chinese Asians: a clinicopathological study and treatment”. JEADV 2001; 25: 842-850.

24. Diven D, Smith E, Pupo R, Lee M. “Hydroquinone-induced localized exogenous ochronosis treated with dermoabreasion and CO2 laser”. J Dermatol 1985; 121: 105-108.

25. Supriya G, Tina S. “Treatment of exogemous ochronosis with a Q-switched Alexandrite (755 nm) laser”. Dermatol Surg 2004; 30: 555-558.